Ironwood Pharmaceuticals | IRWD - EPS Earnings Per Share

Stock Price
4.05
Daily Change
0.12 2.93%
Monthly
25.23%
Yearly
316.80%
Q2 Forecast
3.85

Ironwood Pharmaceuticals reported $-0.01 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q1 Mar/2026 0.19 -0.12 Apr/30




Eps Change Date
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
Agios Pharmaceuticals USD -1.86 0.08 Dec/2025
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Almirall EUR 0.07 0.03 Dec/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Amarin USD 0.14 0.06 Dec/2025
Ardelyx USD 0 0 Dec/2025
Astellas Pharma JPY 56.04 11.82 Dec/2025
AstraZeneca USD 2.12 0.26 Dec/2025
Charles River Laboratories USD 2.39 0.04 Dec/2025
Coherus Biosciences USD -0.43 0.06 Dec/2025
Emergent BioSolutions USD -0.77 0.29 Dec/2023
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
Incyte USD 1.8 0.46 Dec/2025
Ironwood Pharmaceuticals USD -0.01 0.25 Dec/2025
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025
Lexicon Pharmaceuticals USD -0.04 0.01 Dec/2025
MacroGenics USD -0.22 0.49 Dec/2025
Moderna USD -2.11 1.6 Dec/2025
Myriad Genetics USD 0.04 0.33 Dec/2025
Pacira USD 0.06 0.64 Dec/2025
PTC Therapeutics USD -1.67 1.87 Dec/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
Takeda JPY 65.74 73.57 Dec/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
Vanda Pharmaceuticals USD -0.09 0 Dec/2024